Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study

Chapuis Justine; Siu-Paredes Francesca; Pavageau Claire; Amador Gilles; Rude Nathalie; Denis Frédéric

doi:10.1515/tnsci-2020-0003

Translational Neuroscience (Feb 2020)

Anticholinergic drugs and oral health-related quality of life in patients with schizophrenia: a pilot study

Chapuis Justine,
Siu-Paredes Francesca,
Pavageau Claire,
Amador Gilles,
Rude Nathalie,
Denis Frédéric

Affiliations

Chapuis Justine: University Hospital of Tours ,Odontology Department, 37170Chambray-lès-Tours, France
Siu-Paredes Francesca: EA 481 Integrative Neurosciences and Clinical. University Hospital of Besançon, 25000Besançon, France
Pavageau Claire: University Hospital of Tours. Service d’odontologie du CHU de Tours, 37170Chambray-lès-Tours, France
Amador Gilles: Université de Nantes, Faculté d'Odontologie de Nantes, 44000Nantes, France
Rude Nathalie: EA 481 Integrative Neurosciences and Clinical. University Hospital of Besançon, 25000Besançon, France
Denis Frédéric: University Hospital of Tours ,Odontology Department, 37170Chambray-lès-Tours, France

DOI: https://doi.org/10.1515/tnsci-2020-0003
Journal volume & issue: Vol. 11, no. 1
pp. 10 – 16

Abstract

Read online

The aim of this study was to explore, in a sample population of people with schizophrenia (PWS), the role of the anticholinergic burden on the perception of oral health-related quality of life (OHrQoL) in France.

Published in Translational Neuroscience

ISSN: 2081-6936 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: http://www.degruyter.com/view/j/tnsci

About the journal

Abstract

Keywords